Fresenius Medical Care AG
FMCQF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.96B
Close$
$128.33
192.9% upside
Current Fair Value
192.9% upsideUndervalued by 192.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $11.96 Billion |
|---|---|
| Enterprise Value | $22.09 Billion |
| Annual dividend | $1.73 |
| Dividend yield | 3.69% |
| Earnings per Share | $3.35 |
| Beta | 0.71 |
| Outstanding Shares | 268,438,292 |
Return
| Return on Equity | 7.47% |
|---|---|
| Return on Assets | 3.00% |
| Return on Invested Capital | 7.07% |
Valuation & Multiples
| P/E Ratio | 12.17 |
|---|---|
| PEG | -397.68 |
| Price to Sales | 0.61 |
| Price to Book Ratio | 0.88 |
| Enterprise Value to Revenue | 1.14 |
| Enterprise Value to EBIT | 12.95 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 0.89 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 3, 2026
EPS Estimate
$1.22
Consensus analyst estimateRevenue Estimate
$5.47 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$1.29
Consensus analyst estimateRevenue Estimate
$5.58 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Fresenius Medical Care AG & Co. KGaA
111,024 employees
CEO: Rice Powell
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcar...